MedTrace Logo

The Phenylephrine vs. Norepinephrine Infusion Undergoing Cesarean Section

NCT03833895 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 238

Last updated 2020-02-10

No results posted yet for this study

Summary

Compare 0.05 μg/kg/min Norepinephrine and 0.25 μg/kg/min phenylephrine effect on fetus and parturient during Cesarean Section

Conditions

  • Cesarean Section Complications

Interventions

DRUG

Norepinephrine

0.05ug/kg/min Norepinephrine during Cesarean Section Operation

DRUG

Phenylephrine

0.25ug/kg/min phenylephrine during Cesarean Section Operation

DRUG

Ringer's Solution

3 ml/kg/min of LR was administrated according to standard weight.

Sponsors & Collaborators

  • China International Neuroscience Institution

    lead OTHER

Principal Investigators

  • Tianlong Wang, MD,PHD · Xuanwu Hospital, Beijing

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-20
Primary Completion
2019-09-01
Completion
2019-09-02

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03833895 on ClinicalTrials.gov